2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$35.16+$0.010 (+0.03%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.7BMarket Cap
- 102.83%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$35.16+$0.010 (+0.03%)
URGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.15 | ||
Change | -$0.33 (-0.93%) | ||
Open | $35.23 | ||
High | $35.98 | ||
Low | $34.11 | ||
Previous Close | $35.48 | ||
Volume | 689,100 | ||
30-Day Average Volume | 1,004,201 | ||
1-Week Change | -3.99% | ||
1-Month Change | -17.80% | ||
1-Year Change | 102.83% | ||
3-Year Change | 195.63% | ||
5-Year Change | 105.80% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $252.6M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $72.5M | ||
Net Income | -$14.4M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$8.7M | ||
EBITDA | -$8.6M | ||
Net Working Capital | $173.5M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -205 | ||
Enterprise Value/Revenue | 24 | ||
P/B | -13 | ||
P/E | -127 | ||
PEG | -3 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue